<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02985073</url>
  </required_header>
  <id_info>
    <org_study_id>189-16</org_study_id>
    <nct_id>NCT02985073</nct_id>
  </id_info>
  <brief_title>A Comparison Between Biological (Veritas®) vs Non Biological Mesh (TIGR®) in Immediate Breast Reconstruction</brief_title>
  <official_title>The Gothenburg TIGR/Veritas® Study - A Comparison Between Biological (Veritas®) vs Non Biological Mesh (TIGR®) in Immediate Breast Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vastra Gotaland Region</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vastra Gotaland Region</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the outcome using a biological mesh (Veritas®) compared to a non
      biological mesh (TIGR®) in immediate breast reconstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The scientific evidence using different types of mesh in breast reconstruction is low at
      present with very few randomized controlled studies.

      This study aims to compare a biological mesh (Veritas®) compared to a non biological mesh
      (TIGR®) in patients with hereditary increased risk of developing breast cancer operated with
      bilateral immediate breast reconstruction regarding implant loss rate,infections,total
      complication rate,aesthetic outcome, HQOL (health related quality of Life) and economics.

      The patients will be enrolled to the study and sign an informed consent. At the operating
      theater the patient is randomized either to be reconstructed with Veritas® in one breast and
      TIGR® in the other breast..

      The patients will be followed up according to a specified schedule until one year
      postoperatively as above.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total complication rate</measure>
    <time_frame>12 months</time_frame>
    <description>Total complication rate within one year from surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total infection rate</measure>
    <time_frame>30 days</time_frame>
    <description>Total infection rate within 30 days from surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total implant loss rate</measure>
    <time_frame>12 months</time_frame>
    <description>Total implant loss rate within one year from surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aesthetic outcome</measure>
    <time_frame>12 months</time_frame>
    <description>Aesthetic outcome at one year followup will be assessed by analysis of 3-dimensional pre- and post-op pictures in combination with a panel evaluating different aesthetical units of the breast</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HQOL</measure>
    <time_frame>12 months</time_frame>
    <description>Three validated questionaries will be used to assess HQOL: EQ-5D,HAD30 and BreastQ. The patient fills in these preoperatively and one year postop</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cost evaluation</measure>
    <time_frame>12 months</time_frame>
    <description>Cost evaluation at one year followup will be evaluated in cooperation with hospital Economists,calculating the total post per patient with or without a mesh.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Veritas® mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Veritas mesh in conjunction with immediate breast reconstruction on one side</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TIGR® mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of TIGR® mesh in conjunction with immediate breast reconstruction on one side</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Veritas®</intervention_name>
    <description>Biologic mesh</description>
    <arm_group_label>Veritas® mesh</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TIGR®</intervention_name>
    <description>Non biologic mesh</description>
    <arm_group_label>TIGR® mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a confirmed breast cancer gene mutation or a calculated increased risk &gt;
             20% of developing a breast cancer during her lifetime.

        Exclusion Criteria:

          -  All patients that don't fulfill criteria above

          -  Previous breast surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Kölby</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of plastic surgery Sahlgrenska University Hospital Gothenburg Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Håkan Hallberg</last_name>
    <phone>708591203</phone>
    <phone_ext>+46</phone_ext>
    <email>hakan.p.hallberg@vgregion.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard Lewin</last_name>
    <phone>707707654</phone>
    <phone_ext>+46</phone_ext>
    <email>richard.lewin@vgregion.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept . of plastic surgery</name>
      <address>
        <city>Goteborg</city>
        <state>Västra götaland</state>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Kölby</last_name>
      <phone>706451155</phone>
      <phone_ext>+46</phone_ext>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2016</study_first_submitted>
  <study_first_submitted_qc>December 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2016</study_first_posted>
  <last_update_submitted>December 2, 2016</last_update_submitted>
  <last_update_submitted_qc>December 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

